Development Strategy

The Consultants in our Global Regulatory Services team have extensive European Medicines Agency (EMA), Food and Drug Administration (FDA) and national Regulatory Agency experience. They can provide advice and recommendations to ensure the shortest time to market by minimizing any possible barriers.

Our experts can help you understand new and existing guidance to ensure the medicinal product meets all regulatory guidelines; and support with product development strategy from early phase to the marketing authorization submission.

 

BlueReg can also define effective regulatory strategies, aligned with the company’s and regulatory requirements, in order to facilitate post approval activities. Submissions can be prepared, or reviewed for deficiencies, along with  a thorough gap analysis and risk assessment prior to submission to ensure that any questions that may arise from Health Authorities are anticipated and can be prepared for responses.

 

BlueReg can also help with Quality Control and publishing of regulatory submissions, and preparation for Agency meetings.

Our experts

Associated Resources

Define & implement the European Health Authorities consultation strategy for a US-based client

BlueReg made recommendations to a US based client on which Health Authorities in the European...

Learn more

Supporting micro, small and medium sized enterprises (SMEs) not established in the European Economic Area (EEA) in accessing incentives granted by the European Medicines Agency (EMA)

A US‑based client entrusted the European legal representation and the application/granting of their SME status...

Learn more

Support for a Paediatric Investigation Plan in the European Union, for a US-based client

Read our latest PIP case study following our recent webinar!   Discover how BlueReg provided...

Learn more